- Filed
- Mar 26, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Feb 28, 2026 | 359.5M sh |
| Shares Diluted | Q3 2026 · Feb 28, 2026 | 360.6M sh |
| Shares Diluted | Q3 2026 · Feb 28, 2025 | 362M sh |
| Shares Diluted | Q3 2026 · Feb 28, 2025 | 361.9M sh |
| Shares Outstanding | Q3 2026 · Feb 28, 2026 | 358.29M sh |
| Stock Repurchased | Q3 2026 · Feb 28, 2026 | $361.6M |
| Stock Repurchased | Q3 2026 · Feb 28, 2025 | $104.5M |
| Dividends Paid | Q3 2026 · Feb 28, 2026 | $1.17B |
| Dividends Paid | Q3 2026 · Feb 28, 2025 | $1.06B |
| Capex | Q3 2026 · Feb 28, 2026 | $169M |
| Capex | Q3 2026 · Feb 28, 2025 | $131.3M |
| Operating Cash Flow | Q3 2026 · Feb 28, 2026 | $1.98B |
| Operating Cash Flow | Q3 2026 · Feb 28, 2025 | $1.56B |
| Long Term Debt | Q3 2026 · Feb 28, 2026 | $4.55B |
| Long Term Debt | Q3 2026 · May 31, 2025 | $4.55B |
| Short Term Debt | Q3 2026 · Feb 28, 2026 | $0 |
| Short Term Debt | Q3 2026 · May 31, 2025 | $18.6M |
| Cash And Equivalents | Q3 2026 · Feb 28, 2026 | $1.74B |
| Cash And Equivalents | Q3 2026 · May 31, 2025 | $1.63B |
| Cash And Equivalents | Q3 2026 · Feb 28, 2025 | $1.56B |
| Stockholders Equity | Q3 2026 · Feb 28, 2026 | $4.01B |
| Stockholders Equity | Q3 2026 · Nov 30, 2025 | $3.88B |
| Stockholders Equity | Q3 2026 · May 31, 2025 | $4.13B |
| Stockholders Equity | Q3 2026 · Feb 28, 2025 | $4.12B |
| Stockholders Equity | Q3 2026 · Nov 30, 2024 | $3.93B |
| Stockholders Equity | Q3 2026 · May 31, 2024 | $3.8B |
| Current Liabilities | Q3 2026 · Feb 28, 2026 | $7.88B |
| Current Liabilities | Q3 2026 · May 31, 2025 | $6.96B |
| Total Liabilities | Q3 2026 · Feb 28, 2026 | $13.5B |
| Total Liabilities | Q3 2026 · May 31, 2025 | $12.44B |
| Current Assets | Q3 2026 · Feb 28, 2026 | $9.93B |
| Current Assets | Q3 2026 · May 31, 2025 | $8.92B |
| Total Assets | Q3 2026 · Feb 28, 2026 | $17.51B |
| Total Assets | Q3 2026 · May 31, 2025 | $16.56B |
| Eps Diluted | Q3 2026 · Feb 28, 2026 | $1.56 |
| Eps Diluted | Q3 2026 · Feb 28, 2026 | $3.71 |
| Eps Diluted | Q3 2026 · Feb 28, 2025 | $1.43 |
| Eps Diluted | Q3 2026 · Feb 28, 2025 | $3.76 |
| Eps Basic | Q3 2026 · Feb 28, 2026 | $1.56 |
| Eps Basic | Q3 2026 · Feb 28, 2026 | $3.73 |
| Eps Basic | Q3 2026 · Feb 28, 2025 | $1.44 |
| Eps Basic | Q3 2026 · Feb 28, 2025 | $3.78 |
| Sga Expense | Q3 2026 · Feb 28, 2026 | $585.7M |
| Sga Expense | Q3 2026 · Feb 28, 2026 | $1.74B |
| Sga Expense | Q3 2026 · Feb 28, 2025 | $429.8M |
| Sga Expense | Q3 2026 · Feb 28, 2025 | $1.22B |
| Net Income | Q3 2026 · Feb 28, 2026 | $560.3M |
| Net Income | Q3 2026 · Feb 28, 2026 | $1.34B |
| Net Income | Q3 2026 · Feb 28, 2025 | $519.3M |
| Net Income | Q3 2026 · Feb 28, 2025 | $1.36B |
| Operating Income | Q3 2026 · Feb 28, 2026 | $792M |
| Operating Income | Q3 2026 · Feb 28, 2026 | $1.91B |
| Operating Income | Q3 2026 · Feb 28, 2025 | $691.8M |
| Operating Income | Q3 2026 · Feb 28, 2025 | $1.78B |
| Cost Of Revenue | Q3 2026 · Feb 28, 2026 | $431.2M |
| Cost Of Revenue | Q3 2026 · Feb 28, 2026 | $1.26B |
| Cost Of Revenue | Q3 2026 · Feb 28, 2025 | $387.4M |
| Cost Of Revenue | Q3 2026 · Feb 28, 2025 | $1.15B |
| Revenue | Q3 2026 · Feb 28, 2026 | $1.75B |
| Revenue | Q3 2026 · Feb 28, 2026 | $4.75B |
| Revenue | Q3 2026 · Feb 28, 2025 | $1.47B |
| Revenue | Q3 2026 · Feb 28, 2025 | $4.03B |